Effects of clustering nursing intervention on compliance and quality of life of drug-resistant tuberculosis patients after discharge

doi:10.3969/j.issn.2095-3755.2018.03.012

Abstract

Abstract:

Objective To analyze the effects of clustering nursing intervention on compliance and quality of life of drug-resistant tuberculosis patients after discharge.Methods Sixty drug-resistant pulmonary tuberculosis patients admitted from July 2016 to February 2017 were selected as control group and another 60 cases treated from March to October 2017 as observation group. The control group was given routine nursing, and the observation group was given clustering nursing intervention on the basis of routine nursing. The compliance and quality of life before and after nursing were compared between the two groups.Results The therapeutic compliance rate in the observation group was 95.0% (57/60), which was higher than that in the control group (83.3%, 50/60); the difference was statistically significant (χ²=4.23, P<0.05). The scores of body function, psychological function and social function after nursing were (53.18±10.93), (48.67±8.22) and (49.17±9.15) in the observation group and (47.12±11.09), (44.16±6.34) and (43.18±8.29) in the control group, respectively. The scores in the observation group were higher when compared with the control group, with statistical significances (t=3.01, 3.36, and 3.76, all Ps<0.05).Conclusion Clustering nursing intervention can effectively improve the com-pliance and quality of life of drug-resistant tuberculosis patients after discharge.

Key words: Nursing evaluation research, Tuberculosis, multidrug-resistant, Patient compliance, Quality of life, Data interpretation, statistical

Bo CHEN. Effects of clustering nursing intervention on compliance and quality of life of drug-resistant tuberculosis patients after discharge[J]. Journal of Tuberculosis and Lung Health , 2018, 7(3): 205-207. doi: 10.3969/j.issn.2095-3755.2018.03.012

Figures/Tables 1

References 8

[1]	周绚丽 . 集束化护理对重型肝炎患者的影响. 齐鲁护理杂志, 2017,23(11):89-90. doi: 10.3969/j.issn.1006-7256.2017.11.040 URL
[2]	World Health Organization. 耐药结核病规划管理指南(2008年紧急修订版).中国疾病预防控制中心,世界卫生组织结核病研究培训合作中心,中华医学会结核病学分会,译. 北京:中国疾病预防控制中心,世界卫生组织结核病研究培训合作中心,中华医学会结核病学分会, 2008.
[3]	黎意芬, 李佩竹, 邓虹 , 等. 循证护理提高耐药肺结核患者治疗依从性的影响. 现代医院, 2016,16(2):221-222.
[4]	郭晓英 . 针对肺结核合并艾滋病患者采用预见性护理干预的临床分析. 齐齐哈尔医学院学报, 2015,36(23):3582-3583.
[5]	郝晓晖, 姚岚, 孙华 , 等. 老年耐多药肺结核临床特征及转归分析. 中华结核和呼吸杂志, 2014,37(3):188-191. doi: 10.3760/cma.j.issn.1001-0939.2014.03.009 URL
[6]	潘陈丽, 陈红, 余白露 , 等. 动机性访谈对耐多药肺结核患者负性情绪的影响. 中华全科医学, 2015,13(10):1710-1711.
[7]	范凌, 纪风兵, 周琴 . 干扰素联合化疗对耐药肺结核临床症状及免疫功能的影响. 西部医学, 2017,29(6):817-820.
[8]	迟丽茹 . 集束化护理对减少呼吸内科老年患者跌倒事件的干预效果分析. 东南国防医药, 2017,19(6):649-652.

组别	躯体功能		心理功能		社会功能		物质生活
组别	护理前	护理后	护理前	护理后	护理前	护理后	护理前	护理后
观察组(60例)	36.19±11.25	53.18±10.93	38.11±8.16	48.67±8.22	38.45±9.43	49.17±9.15	45.87±9.63	57.32±10.43
对照组(60例)	36.52±11.78	47.12±11.09	38.75±8.49	44.16±6.34	38.91±9.35	43.18±8.29	46.08±9.82	56.37±11.79
t值	0.16	3.01	0.42	3.36	0.27	3.76	0.12	0.47
P值	>0.05	<0.05	>0.05	<0.05	>0.05	<0.05	>0.05	>0.05

[1]	Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112.
[2]	Xu Yannan, Fang Zihao, Zhao Wenli, Zheng Jiaxiong, Liu Suyang, Lin Jianxiong, Ji Liwei, Chang Qiaocheng. Characterisation of isoniazid-resistant Mycobacterium tuberculosis mutations in China [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 14-21.
[3]	Wan Ying, Pang Xuewen, Zhang Fan. Evaluation on effect of health promotion for tuberculosis prevention and control in Tianjin City from 2010 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 22-29.
[4]	Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34.
[5]	Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39.
[6]	Yang Yan, Dong Wen, Chen Jianjun, Zhang Yu. Epidemiologic characteristics of pulmonary tuberculosis in Zhuxi County, Shiyan City (2014-2023) [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 40-45.
[7]	Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54.
[8]	Yan Qinghu, Xue Feng, Yu Yong, Qin Yi, Yan Qingmei, Cui Jia. The value of ultrasound-guided microwave ablation in the treatment of localized tuberculous lesions [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 55-60.
[9]	Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67.
[10]	Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72.
[11]	Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78.
[12]	Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13.
[13]	Zhang Ying, Guo Chunhui. Research progress in the treatment of tuberculous tracheobronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 87-93.
[14]	Yang Shuqi, Li Feng. Advances in PD1/PD-L1 inhibitors in tuberculosis research [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 94-101.
[15]	Hu Xinyang, Gao Jingtao. Interpretation of WHO global tuberculosis report 2024 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 500-504.